Development of more effective TB drugs and vaccines is a pressing, unmet medical need.
A study is set to find out whether Bacillus Calmette-Guérin (BCG) vaccine — made of comparatively harmless microbial cousins to human TB — might safely work as a stand-in for real TB germs in future clinical trials to assess new drugs and better vaccines to stop the disease.
Read the full story at Fred Hutchinson Cancer Center.